Growing prevalence of allergic disorders caused by environmental factors or hosts is expected to drive the market for allergy diagnostic market over the forecast period. Allergy is hypersensitivity disorder in the immune system which may cause diseases such as asthma. Increasing investment in In-vitro market coupled with favorable government support against animal testing is likely to boost the growth for this market. Increasing investment in healthcare sector, growing geriatric population base and favorable policies of government is likely to drive the market over the forecast period. Rising prevalence of lifestyle associated diseases complemented with changing food habits is another major driver for this market. Innovations in technology led to the introduction of advanced lab-automation devices and are efficient in controlling ADR (Adverse Drug Reaction).Furthermore, increasing access to health insurance facility and rising personal disposable income are expected to trigger the growth of this market by 2022. The emerging nations such as India, China and Brazil are expected to witness significant growth opportunity over the forecast period owing to large untapped market.
To request a sample copy or view summary of this report, click the link below:
By allergen type, the global allergy diagnostic market was dominated by food allergens, in 2014. Due to rapid increase in pollution level and other respiratory disorders the inhaled allergens segment is anticipated to witness lucrative growth by 2022. On the basis of products, consumable held the largest share in terms of revenue owing to rapidly shifting lifestyle coupled with changing food habits. On the basis of end-use market hospitals, accounted for the largest share in 2014. Increasing incidences of ADR is anticipated to drive the market for hospitals and diagnostic centers.
To request a sample copy or view TOC of this...